- Home
- NPT vs MBOT Comparison
NPT vs MBOT Comparison
Compare NPT & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | MBOT |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | China | United States |
| Employees | N/A | 22 |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.3M | 73.2M |
| IPO Year | 2024 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NPT | MBOT |
|---|---|---|
| Price | $1.78 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 14.7K | ★ 815.3K |
| Earning Date | 11-17-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $377.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.14 | $0.93 |
| 52 Week High | $22.38 | $2.86 |
Technical Indicators
Market Signals| Indicator | NPT | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 36.17 | 46.29 |
| Support Level | $1.23 | N/A |
| Resistance Level | $3.61 | $2.69 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 38.65 | 56.00 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.